Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEVRO CORP | Chief Commercial Officer | Common Stock | 86K | $1.67M | $19.39 | May 28, 2023 | Direct |
Acutus Medical, Inc. | Director | FORM 4 | 21K | $3.96K | $0.19 | Jun 15, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AFIB | Acutus Medical, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
NVRO | NEVRO CORP | May 28, 2023 | 1 | -$30.2K | 4 | May 31, 2023 | Chief Commercial Officer |
NVRO | NEVRO CORP | Mar 7, 2023 | 1 | $0 | 4 | Mar 9, 2023 | Chief Commercial Officer |
NVRO | NEVRO CORP | Mar 2, 2023 | 1 | -$67.3K | 4 | Mar 6, 2023 | Chief Commercial Officer |
NVRO | NEVRO CORP | Feb 28, 2023 | 1 | -$148K | 4 | Mar 2, 2023 | Chief Commercial Officer |
NVRO | NEVRO CORP | Aug 6, 2022 | 1 | -$206K | 4 | Aug 8, 2022 | Chief Commercial Officer |
AFIB | Acutus Medical, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
NVRO | NEVRO CORP | Mar 2, 2022 | 1 | -$145K | 4 | Mar 4, 2022 | Chief Commercial Officer |
NVRO | NEVRO CORP | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Chief Commercial Officer |
AFIB | Acutus Medical, Inc. | Aug 10, 2021 | 2 | $0 | 4 | Aug 12, 2021 | Director |
AFIB | Acutus Medical, Inc. | Aug 10, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Director |
NVRO | NEVRO CORP | Aug 6, 2021 | 1 | -$523K | 4 | Aug 10, 2021 | Chief Commercial Officer |